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ABSTRACT 
 
A series of thiophene appended substituted pyrimidin-2-one analogues were synthesized by an accessible approach. 
The reaction of chalcones 1(a-e) and urea 2 in the presence potassium hydroxide in ethanol yielded 6-aryl-4-
(thiophen-2-yl)-5,6-dihydropyrimidin-2(1H)-ones, 3(a-e) in good yields. The synthesized new compounds were 
characterized by 1H NMR, 13C NMR, Mass spectral studies and elemental analysis and were screened for their 
antifungal susceptibility against different fungi species. 
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INTRODUCTION 
 
The exploitation of a simple molecule with different functionalities to the synthesis of heterocycles is a worthwhile 
contribution in heterocyclic chemistry [1]. Literature reveals many synthetic strategies for the pyrimidine derivatives 
and their biological potency. For instance, 2-Arylsteroidal[3,2-d]pyrimidines were prepared from 2-
Hydroxymethylene-3-ketosteroid, aromatic aldehyde and ammonium acetate mixed with silica gel under MW 
conditions [2]. An unprecedented approach to 4,5-disubstituted pyrimidine derivatives by a ZnCl2-catalyzed three-
component coupling reaction [3]. A mixture of 4-acetylpyridine and substituted benzaldehydes reacts in the presence 
of KOH to form chalcones, which undergoes cyclocondensation with urea to yield substituted pyrimidines [4]. α,β-
unsaturated ketones or chalcones were considered as useful synthons for the construction of bioactive molecules 
such as pyrimidines [3], pyrazolines [5.6], thiazepines [7,8], isoxazoles [9] etc. 
 
Hassan and co-workers [10] reported the synthesis of 4-amino-5-pyrimidinecarbonitrile derivatives by a three-
component reaction of malononitrile, aldehydes and N-unsubstituted amidines. A new and efficient synthesis of 
pyrimido[4,5-d]pyrimidine-2,4-dione derivatives through the reaction of 6-aminouracils and N,N-
bis(arylmethylidene)arylmethane in the presence of molecular iodine as a readily available and feasible catalyst [11]. 
Copper/6-methylpicolinic acid catalyzed coupling reaction of substituted 5-bromopyrimidin-4-amines with alkynes 
and subsequent cyclization took place in DMSO afford 2-chloro-pyrrolo[2,3-d]pyrimidines in moderate to excellent 
yields [12]. 
 
In view of the enormous quantity of synthetic and biological applications associated with the pyrimidines, we herein 
report the synthesis of a series of novel pyrimidin-2-one analogues by an accessible procedure and the results of 
their antifungal susceptibility. 
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EXPERIMENTAL SECTION 
 
Melting points were determined by open capillary method and are uncorrected. The 1H NMR and 13C NMR spectra 
were recorded on Agilent-NMR 400 MHz and 100 MHz spectrophotometer respectively in CDCl3 with TMS as an 
internal standard. The chemical shifts are expressed in δ ppm. Mass spectra were obtained on Mass Lynx SCN781 
spectrophotomer TOF mode. Elemental analysis was performed on a Thermo Finnigan Flash EA 1112 CHN 
analyzer. Chromatographic separations were carried out on silica gel (70-230 mesh, Merck) column using hexane: 
ethyl acetate (4:1) as eluent.  
 
General procedure for the synthesis of 6-Aryl-3-(thiophen-2-yl)-5,6-dihydropyrimidin-2(1H)-ones, 3(a-e): A 
mixture of substituted chalcones 1(a-e) (0.001mol) and urea 2 (0.001mol) and potassium hydroxide (0.02 mol) in 
ethyl alcohol (20 mL) was refluxed on a water bath for 6-8 hrs. The progress of the reaction was monitored by TLC. 
After completion of the reaction, the mixture was poured into ice cold water and stirred. The solid separated was 
filtered, washed with ice cold water and recrystallized from ethyl alcohol to obtain target molecules 3(a-e) in good 
yields. The reaction pathway is depicted in scheme-1.  
 
 
Antifungal activity of the synthesized compounds was done by paper disc diffusion method [13, 14]. The test 
compounds 3(a-e) at the concentration of 50 µg/mL in methanol in the nutrient agar media were screened for their 
antifungal activity against fungi species  Aspergillus niger, Aspergillus flavus, Fusarium oxysporium. The antibiotic 
nystatin was used as the standard drug against fungi species.  
 
6-(4-Fluorophenyl)-4-(thiophen-2-yl)-5,6-dihydropyrimidin-2(1H)-one, 3a: Obtained from 3-phenyl-1-(thiophen-
2-yl)prop-2-en-1-one, 1a (0.001 mol) and urea, 2 (0.001 mol) as white solid in 72% yield, m.p. 165-168 ºC. MS 
(m/z): 275 (M+H, 15), 274 (M+, 100). Anal. Calcd. for C14H11FN2OS: C, 61.30; H, 4.04; N, 10.21%; Found: C, 
61.12; H, 4.09; N, 10.09%.  
 
4-(Thiophen-2-yl)-6-(p-tolyl)-5,6-dihydropyrimidin-2(1H)-one, 3b: Obtained from 3-(4-methylphenyl)-1-
(thiophen-2-yl)prop-2-en-1-one, 1b (0.001 mol) and urea, 2 (0.001 mol) as white solid in 78% yield, m.p. 118-122 
ºC. 1H NMR (CDCl3): δ 1.550-1.602 (dd, 1H, C5-Ha), 1.811-1.868 (dd, 1H, C5-Hb), 2.289 (s, 1H, CH3), 4.810-4.846 
(dd, 1H, C6-H), 7.120 (dd, 2H, Ar-H), 7.229 (dd, 2H, Ar-H), 7.346-7.658 (m, 3H, thiophene ring-H), 8.134 (s, 1H, -
NH). 13C NMR (CDCl3): δ 21.22 (1C, CH3), 43.86 (1C, C-5), 46.32 (1C, C-6), 123.30 (2C, Ar-C), 124.34 (1C, 5m 
ring-C), 125.60 (1C, 5m ring-C), 127.32 (1C, 5m ring-C), 127.80 (1C, 5m ring-C), 128.68 (2C, Ar-C), 135.10 (1C, 
Ar-C), 139.36 (1C, Ar-C), 162.14 (1C, C=O), 164.12 (1C, C-4). MS (m/z): 271 (M+H, 12), 270 (M+, 100). Anal. 
Calcd. for C15H14N2OS: C, 66.64; H, 5.22; N, 10.36%; Found: C, 66.47; H, 5.13; N, 10.14%. 
 
6-(3,4-Dimethoxyphenyl)-4-(thiophen-2-yl)-5,6-dihydropyrimidin-2(1H)-one, 3c: Obtained from 3-(3,4-
dimethoxyphenyl)-1-(thiophen-2-yl)prop-2-en-1-one, 1c (0.001 mol) and urea, 2 (0.001 mol) as white solid in 77% 
yield, m.p. 135-137 ºC. 1H NMR (CDCl3): δ 1.523-1.614 (dd, 1H, C5-Ha), 1.832-1.873 (dd, 1H, C5-Hb), 3.856 (s, 6H, 
OCH3), 4.824-4.858 (dd, 1H, C6-H), 6.981-7.582 (m, 6H, Ar-H, thiophene ring-H), 8.105 (s, 1H, -NH). 13C NMR 
(CDCl3): δ 43.60 (1C, C-5), 46.83 (1C, C-6), 55.78 (2C, OCH3), 108.14 (1C, Ar-C), 118.10 (1C, Ar-C), 120.07 (1C, 
Ar-C), 124.44 (1C, 5m ring-C), 125.70 (1C, 5m ring-C), 127.42 (1C, 5m ring-C), 127.89 (1C, 5m ring-C), 135.10 
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(1C, Ar-C), 146.52 (1C, Ar-C), 147.64 (1C, Ar-C), 162.20 (1C, C=O), 164.56 (1C, C-4). MS (m/z): 317 (M+H, 22), 
316 (M+, 100). Anal. Calcd. for C16H16N2O3S: C, 60.74; H, 5.10; N, 8.85%; Found: C, 60.54; H, 5.00; N, 8.66%. 
 
6-(4-Nitrophenyl)-4-(thiophen-2-yl)-5,6-dihydropyrimidin-2(1H)-one, 3d: Obtained from 3-(4-Nitrophenyl)-1-
(thiophen-2-yl)prop-2-en-1-one, 1d (0.001 mol) and urea, 2 (0.001 mol) as white solid in 82% yield, m.p. 115-118 
ºC. 1H NMR (CDCl3): δ 1.536-1.632 (dd, 1H, C5-Ha), 1.832-1.865 (dd, 1H, C5-Hb), 4.811-4.847 (dd, 1H, C6-H), 
7.334-7.502 (m, 3H, thiophene ring-H), 7.598 (dd, 2H, Ar-H), 8.108 (s, 1H, -NH), 8.230 (dd, 2H, Ar-H). 13C NMR 
(CDCl3): δ 43.12 (1C, C-5), 46.33 (1C, C-6), 1234.30 (2C, Ar-C), 124.64 (2C, Ar-C), 124.98 (1C, 5m ring-C), 
125.53 (1C, 5m ring-C), 127.32 (1C, 5m ring-C), 127.78 (1C, 5m ring-C), 148.10 (1C, Ar-C), 149.20 (1C, Ar-C), 
162.26 (1C, C=O), 163.65 (1C, C-4). MS (m/z): 302 (M+H, 19), 302 (M+, 100). Anal. Calcd. for C14H11N3O3S: C, 
55.80; H, 3.68; N, 13.95%; Found: C, 55.54; H, 3.48; N, 13.76%. 
 
6-(Furan-2-yl)-4-(thiophen-2-yl)-5,6-dihydropyrimidin-2(1H)-one, 3e: Obtained from 3-(Furan-2-yl)-1-(thiophen-
2-yl)prop-2-en-1-one, 1e (0.001 mol) and urea, 2 (0.001 mol) as white solid in 66% yield, m.p. 160-164 ºC. 1H NMR 
(CDCl3): δ 1.592-1.646 (dd, 1H, C5-Ha), 1.872-1.910 (dd, 1H, C5-Hb), 5.011-5.052 (dd, 1H, C6-H), 6.551-7.442 (m, 
6H, thiophene furan ring-H), 8.120 (s, 1H, -NH). 13C NMR (CDCl3): δ 43.09 (1C, C-5), 46.32 (1C, C-6), 108.13 
(1C, 5m ring-C), 109.92 (1C, 5m ring-C), 123.87 (1C, 5m ring-C), 124.02 (1C, 5m ring-C), 126.96 (1C, 5m ring-C), 
127.24 (1C, 5m ring-C), 138.10 (1C, 5m ring-C), 151.10 (1C, 5m ring-C), 162.30 (1C, C=O), 163.25 (1C, C-4). MS 
(m/z): 247 (M+H, 16), 246 (M+, 100). Anal. Calcd. for C12H10N2O2S: C, 58.52; H, 4.09; N, 11.37%; Found: C, 
58.35; H, 4.01; N, 11.23%. 
 
RESULTS AND DISCUSSION 
 
The general synthetic pathway employed is depicted in the scheme-1. The structure proof of the products was 
provided by 1H NMR, 13C NMR, MS studies and elemental analysis.  
 
The structural assignments were made by NMR analysis by considering compound 2a as the representative 
compound. In its 1H NMR spectra, Ha, Hb and Hc protons of the pyrimidine ring appeared as a doublet of doublet. 
The doublets of Ha appeared in the region δ 1.556-1.608 ppm; doublets of Hb appeared in the region δ 1.802-1.870 
ppm; and that of Hc in the region δ 4.815-4.852 ppm. Doublets of Ha and Hb are due to diastereotopic nature of 
methylene protons. Among Ha, Hb and Hc protons, Hc is the most deshielded due to its close proximity to 
electronegative NH function. Hc couples not only with Ha but also with Hb and appears as doublet of doublet instead 
of a triplet; exhibited a typical ABX spin system with Hc as a doublet of doublets (Fig-1). NH proton is highly 
deshielded due to electron withdrawing adjacent C=O group and appears as singlet at δ 8.125 ppm. Due to para 
substitution, two aromatic protons each appeared as doublet of doublet at δ 7.021 ppm. and δ 7.228 ppm. Three 
thiophene ring protons appeared as multiplet in the region δ 7.341-7.612 ppm. All the synthesized compounds 2(b-e) 
showed the similar 1H NMR signals. 
 
 
 
In 13C NMR, the compound 2a showed signals due to C-5-atom at δ 43.72 ppm, for the C-6 atom at δ 46.51 ppm. 
The C-4 atom signal appeared at δ 163.20 ppm. An intense signal appeared at δ 162.33 ppm was due to C=O carbon 
atom. An array of signals appeared at δ 114.32 and 128.60 ppm. for two carbon each, and at δ 124.03, 125.64, 
127.40, 127.86, 138.10 and 159.13 ppm. for one carbon each was assigned to aromatic and thiophene ring carbons. 
The synthesized compounds 2(b-e) showed similar consistent pattern signal in the 13C NMR spectra, which strongly 
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support the structure of the products. All new compounds gave stable molecular mass MH+ peak and a base peak at 
corresponding M+ ion. Satisfactorily elemental analysis further supports structure of the products. 
 
Antimicrobial activity: The results of antifungal activity of the synthesized compounds 2(a-e) against different 
fungi species were depicted in Fig-2. 
 
 
 
The results of the study revealed that synthesized new compounds 2(a-e) have shown moderate to good antifungal 
activity against all the tested organisms. The compounds 2a, 2b and 2c showed remarkable inhibition effect on all 
the tested organisms in comparison with the standard drug. The compounds 2d and 2e having strong electron 
withdrawing –NO2 substitution and furan ring showed moderate inhibition against all the fungi strains tested.  
 
CONCLUSION 
 
The easy and accessible procedure for the synthesis of novel pyrimidin-2-ones, the efficacy of some of the 
synthesized molecules as antifungal agents validates the significance of this study.  Among the series of the 
compounds reported, the compounds 2a, 2b and 2c can be used as potential antifungal agents. 
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